Financial Year |
March 31 2023 |
Monetary Funds |
316,771,281.95 |
Held-for-trading Financial Assets |
80,055,027.40 |
Notes Receivable |
725,050.00 |
Accounts Receivable |
412,047,082.62 |
Advances to Suppliers |
14,403,692.04 |
Other Receivables |
21,068,347.73 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
140,774,640.49 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
4,274,906.17 |
Total Current Assets |
1,015,913,460.79 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
37,607,937.97 |
Investment Properties |
23,350,268.59 |
Fixed Assetes |
51,414,461.98 |
Under-construction Projects |
-- |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
70,491,446.98 |
R&D expenses |
61,814,227.67 |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
22,669,005.19 |
Deferred Income Tax Assets |
18,135,136.13 |
Other Non-Current Assets |
359,484,022.80 |
Sub-Total of Non-Current Assets |
708,871,989.80 |
Total Assets |
1,724,785,450.59 |
Short-Term Loans |
331,716,229.02 |
Trading Financial liabilities |
-- |
Notes Payable |
4,557,957.84 |
Accounts Payable |
120,115,378.29 |
Accounts Received In Advance |
228,006.72 |
Employee Compensation Payable |
50,794,989.58 |
Taxes Payable |
5,913,740.39 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
23,443,009.37 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
29,965,984.65 |
Other Current Liabilities |
123,765.63 |
Sub-Total of Current Liabilities |
604,420,135.04 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
8,254.11 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
48,535,241.67 |
Total Liabilities |
652,955,376.71 |
Paid-In Capital(Or Share Stock) |
226,379,797.00 |
Capital Surplus |
950,984,039.45 |
Surplus Reserve |
41,559,373.43 |
LESS:Treasury Stock |
18,941,328.00 |
Undistributed Profits |
-124,987,348.47 |
Minority Stockholder's Interest |
-13,305.62 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,071,843,379.50 |
Owner's Equity(Stockholder's Equity) |
1,071,830,073.88 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
1,724,785,450.59 |